These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Understanding herb and dietary supplement use in patients with epilepsy. Kaiboriboon K; Guevara M; Alldredge BK Epilepsia; 2009 Aug; 50(8):1927-32. PubMed ID: 19486356 [TBL] [Abstract][Full Text] [Related]
43. Perceived efficacy, indications, and information sources for medically indigent patients and their healthcare providers regarding dietary supplements. Clay PG; Glaros AG; Clauson KA Ann Pharmacother; 2006 Mar; 40(3):427-32. PubMed ID: 16507626 [TBL] [Abstract][Full Text] [Related]
44. Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States. Wu KM; Ghantous H; Birnkrant DB Food Chem Toxicol; 2008 Aug; 46(8):2606-10. PubMed ID: 18614266 [TBL] [Abstract][Full Text] [Related]
45. The incidence of potential interactions between dietary supplements and prescription medications in cancer patients at a Veterans Administration Hospital. Lee AH; Ingraham SE; Kopp M; Foraida MI; Jazieh AR Am J Clin Oncol; 2006 Apr; 29(2):178-82. PubMed ID: 16601439 [TBL] [Abstract][Full Text] [Related]
46. Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. London B; Albert C; Anderson ME; Giles WR; Van Wagoner DR; Balk E; Billman GE; Chung M; Lands W; Leaf A; McAnulty J; Martens JR; Costello RB; Lathrop DA Circulation; 2007 Sep; 116(10):e320-35. PubMed ID: 17768297 [No Abstract] [Full Text] [Related]
47. Drugs and other product choices. Hyman PM; Carvajal R Dermatol Ther; 2009; 22(3):216-24. PubMed ID: 19453345 [TBL] [Abstract][Full Text] [Related]
48. Quality of manufacturer provided information on safety and efficacy claims for dietary supplements for colonic health. Hass DJ; Lewis JD Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):578-86. PubMed ID: 16700078 [TBL] [Abstract][Full Text] [Related]
49. Scientific and regulatory aspects of nutraceutical products in the United States. Kottke MK Drug Dev Ind Pharm; 1998 Dec; 24(12):1177-95. PubMed ID: 9876574 [TBL] [Abstract][Full Text] [Related]
50. Medical renaissance. Bullock K Trustee; 1997 Oct; 50(9):5-6. PubMed ID: 10173685 [No Abstract] [Full Text] [Related]
51. Potential for interactions between dietary supplements and prescription medications. Sood A; Sood R; Brinker FJ; Mann R; Loehrer LL; Wahner-Roedler DL Am J Med; 2008 Mar; 121(3):207-11. PubMed ID: 18328304 [TBL] [Abstract][Full Text] [Related]
53. Dietary supplements in the management of diabetes: potential risks and benefits. Geil P; Shane-McWhorter L J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S59-65. PubMed ID: 18358258 [TBL] [Abstract][Full Text] [Related]
54. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division. Villafranco JE; Lustigman AB Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227 [No Abstract] [Full Text] [Related]
55. Quality assurance and safety of herbal dietary supplements. Fu PP; Chiang HM; Xia Q; Chen T; Chen BH; Yin JJ; Wen KC; Lin G; Yu H J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2009 Apr; 27(2):91-119. PubMed ID: 19412857 [TBL] [Abstract][Full Text] [Related]
56. Herbs and other dietary supplements: current regulations and recommendations for use to maintain health in the management of the common cold or other related infectious respiratory illnesses. Mathes A; Bellanger R J Pharm Pract; 2010 Apr; 23(2):117-27. PubMed ID: 21507804 [TBL] [Abstract][Full Text] [Related]
57. Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey. Bush TM; Rayburn KS; Holloway SW; Sanchez-Yamamoto DS; Allen BL; Lam T; So BK; Tran de H; Greyber ER; Kantor S; Roth LW Altern Ther Health Med; 2007; 13(2):30-5. PubMed ID: 17405676 [TBL] [Abstract][Full Text] [Related]
58. Dietary supplement use in people being treated for depression. Silvers KM; Woolley CC; Hedderley D Asia Pac J Clin Nutr; 2006; 15(1):30-4. PubMed ID: 16500875 [TBL] [Abstract][Full Text] [Related]
59. Herbs and dietary supplement use in patients with stage 5 chronic kidney disease. Burrowes JD; Van Houten G Nephrol Nurs J; 2006; 33(1):85-8. PubMed ID: 16538934 [TBL] [Abstract][Full Text] [Related]
60. Analysis of green tea extract dietary supplements by micellar electrokinetic chromatography. Weiss DJ; Austria EJ; Anderton CR; Hompesch R; Jander A J Chromatogr A; 2006 Jun; 1117(1):103-8. PubMed ID: 16600259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]